17
Novel FDA PMA & de novo 510k approvals
40
U.S. Commercial Product Launches
34
Level I Clinical Trials
25
Strategic Financings
26
Exits by IPO or M&A
VENSANA CAPITAL
CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠